Annual report pursuant to Section 13 and 15(d)

Inventory

v3.3.1.900
Inventory
12 Months Ended
Dec. 31, 2015
Inventory Disclosure [Abstract]  
Inventory

7.

Inventory

The components of net inventory at December 31, 2015 and 2014, net of reserves of $345,000 and $539,000, respectively, are as follows:

 

 

 

2015

 

 

2014

 

Materials

 

$

330,000

 

 

$

 

Work-in-process

 

 

392,457

 

 

 

1,034,476

 

Finished goods

 

 

275,168

 

 

 

436,936

 

Reserves

 

 

(344,719

)

 

 

(539,027

)

 

 

$

652,906

 

 

$

932,385

 

During 2015 and 2014, we capitalized $1.1 million and $110,000, respectively, of inventory costs associated with our Lymphoseek product.  During 2015 and 2014, we utilized $446,000 and $198,000, respectively, of previously capitalized Lymphoseek inventory due to the consumption of the Lymphoseek material for product testing and development purposes.

During 2015, we wrote off $120,000 of materials related to production issues.  During 2015 and 2014, we recorded obsolescence reserves of $52,000 and $539,000 of Lymphoseek inventory related to specific lots that expired or were nearing product expiry and therefore were no longer expected to be sold.